Evidence map›Paper›PMID 39956827›Full record

ArticleNature communications2025

Chiral plasmonic superlattices from template-assisted assembly of achiral nanoparticles.

Xiaoyu Qi, Luis Alberto Pérez, Jose Mendoza-Carreño, Miquel Garriga, Maria Isabel Alonso, Agustín Mihi

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Near-Unity Chiral Lasing Enabled by Quasi-Bound States in the Continuum.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyu Qi
Luis Alberto PérezInstitute of Materials Science of Barcelona ICMAB-CSIC; Campus UAB, Bellaterra, Spain. lperez@icmab.es.ORCID http://orcid.org/0000-0003-2802-4891
Jose Mendoza-CarreñoInstitute of Materials Science of Barcelona ICMAB-CSIC; Campus UAB, Bellaterra, Spain.ORCID http://orcid.org/0000-0001-8650-9913
Miquel GarrigaInstitute of Materials Science of Barcelona ICMAB-CSIC; Campus UAB, Bellaterra, Spain.ORCID http://orcid.org/0000-0002-6683-0790
Maria Isabel AlonsoInstitute of Materials Science of Barcelona ICMAB-CSIC; Campus UAB, Bellaterra, Spain.ORCID http://orcid.org/0000-0001-7669-5871
Agustín MihiInstitute of Materials Science of Barcelona ICMAB-CSIC; Campus UAB, Bellaterra, Spain. amihi@icmab.es.ORCID http://orcid.org/0000-0003-3821-7881

Funding

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PDC2021-121475-I00
6 · The paper itself

Abstract

The creation of chiral plasmonic architectures combining templates with achiral plasmonic particles leads to strong chiroptical responses that can be finely tuned via the characteristics of the colloidal building blocks. Here we show how elastomeric molds, pre-patterned with a hexagonal array of triskelia motifs, can guide the assembly of ordinary noble metal colloids into chiral plasmonic architectures with strong dichroism values. Under normal incidence, the chiral arrays made with gold and silver colloids showed g-factors of 0.18 and 0.4, respectively. In all cases, increasing the size of the colloid allows tuning the optical properties of the structure in the VIS-NIR range. When a superstrate layer is deposited onto the structures, the extrinsic chirality response of the 2D superlattice is revealed and strongly amplified by the chiral motifs under oblique inspection, leading to g-factors of ± 1.2 at ± 14°. Finally, these chiral plasmonic resonances sustained by the triskelion array are used to produce circularly polarized photoluminescence from achiral organic dyes placed on top with up to 20% of dissymmetry.

Identifiers

PMID39956827
PMCPMC11830766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.